Administrative Core
行政核心
基本信息
- 批准号:10378613
- 负责人:
- 金额:$ 119.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-15 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdvertisementsAdvisory CommitteesAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAnimal WelfareBiological MarkersClinicalClinical ResearchClinical TrialsCollaborationsCommunicationCommunitiesDataData SetDevelopmentDiseaseEnsureEventFaculty RecruitmentFinancial SupportFutureGoalsHeterogeneityHuman ResourcesLeadLeadershipMarshalMassachusettsMentorsMissionMonitorNerve DegenerationParticipantPoliciesProcessResearchResearch PersonnelResearch PriorityResearch Project GrantsResourcesRoleRotationSamplingScienceSeriesStrategic PlanningStressSumTechnologyTimeTissuesTrainingTraining SupportUnited States National Institutes of HealthWorkeducation researchfight againsthuman subjectmeetingsneuroimagingnew growthnew technologyprogramsrecruitsymposiumtooltransmission process
项目摘要
Massachusetts Alzheimer’s Disease Research Center: Administrative Core
The Administrative Core of the Massachusetts Alzheimer’s Disease Research Center (MADRC) leads the
Center’s efforts to contribute to our understanding of Alzheimer’s disease and Alzheimer’s disease related
disorders (AD/ADRD). The Administrative Core sets the strategic priorities and outlines the tactics: We
created the strategic plan for this application, with a focus on two closely related topics: heterogeneity of
dementing illness and accelerating a path towards a cure. We coordinate efforts of the various components of
the Center with each other, and coordinate planning for optimal utilization of resources within the Center and
by leveraging institutional capabilities. We also act as an interface for the Center to optimize connections with
the lay public, with institutional stake holders, and with national efforts. We take an active role in future
planning, faculty recruitment and retention, and training of future leaders. The Administrative core coordinates
interactions to develop trans-ADRC and other outside research projects. We oversee the research and grant
administrative processes, including human subjects, animal welfare (if needed by a Developmental Project),
scientific integrity, data and sample sharing, and financial policy requirements. We ensure timely and complete
communication with NACC, timely and complete submission of samples to NCRAD, and continued
participation in NIA summits and similar national forums.
The Core is assisted and advised by an Executive Committee, composed of Core leaders and institutional
leaders, and by a series of special purpose committees, including Developmental Projects, Clinical Studies
Committee (which also oversees clinical trials interactions), Tissue and Biofluid distribution committee, Data
Committee, ORE and the Community Advisory Board committee, and a REC committee. We are also advised
by and assisted by an External Advisory Committee that will provide input on all aspects of Center activities.
Importantly, we recruit, select, and monitor, and mentor the recipients of the exciting new Developmental
Projects program, to which we are devoting maximal allowed resources. The Chair of the External Advisory
Committee also chairs the selection committee; we hope to use this program to further enhance the growth of
new science and new investigators, as another tool to build the future of our program. In sum, the
Administrative Core provides leadership and support for both the broad efforts of the Center and support for
the day-to-day activities that allow the Center have a maximal impact in our fight against AD/ADRD.
马萨诸塞州阿尔茨海默氏病研究中心:行政核心
马萨诸塞州阿尔茨海默氏病研究中心(MADRC)的行政核心领导
中心为我们理解阿尔茨海默氏病和与阿尔茨海默氏病有关的努力
疾病(AD/ADRD)。行政核心设定了战略重点并概述了策略:我们
为此应用创建了战略计划,重点是两个密切相关的主题:异质性
痴呆疾病和加速途径通往治愈的道路。我们协调各个组成部分的工作
彼此之间的中心,并协调中心内资源最佳利用的计划
通过利用机构能力。我们还充当中心的接口,以优化与
外行公众,拥有机构持有人,并在国家努力下进行。我们在未来发挥积极作用
计划,教师招聘和保留以及对未来领导者的培训。行政核心坐标
开发反式ADRC和其他外部研究项目的互动。我们监督研究并授予
行政程序,包括人类受试者,动物福利(如果是发展项目的必要),
科学完整性,数据和样本共享以及财务政策要求。我们确保及时完整
与NACC进行沟通,及时并完全提交样品向NCRAD进行交流,然后继续
参加NIA峰会和类似的国家论坛。
核心由执行委员会协助和建议,由核心领导人和机构组成
领导者以及一系列特殊目的委员会,包括发展项目,临床研究
委员会(还监督临床试验相互作用),组织和生物流体分销委员会,数据
委员会,矿石和社区顾问委员会委员会以及REC委员会。我们也被告知
由外部咨询委员会通过并协助,该委员会将提供有关中心活动各个方面的意见。
重要的是,我们招募,选择和监视,并为令人兴奋的新发展的接受者提供心理
项目计划,我们投入最大允许的资源。外部咨询主席
委员会还主持选拔委员会;我们希望使用该计划进一步增强
新科学和新研究人员,是建立我们计划未来的另一种工具。总而言之
行政核心为中心的广泛努力和支持提供领导和支持
允许该中心的日常活动对我们与AD/ADRD的斗争产生最大影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRADLEY T. HYMAN其他文献
BRADLEY T. HYMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRADLEY T. HYMAN', 18)}}的其他基金
Discovery and development of apoE4 correctors for the treatment of Alzheimer's disease
发现和开发用于治疗阿尔茨海默病的 apoE4 校正剂
- 批准号:
10901029 - 财政年份:2023
- 资助金额:
$ 119.21万 - 项目类别:
MGH Diseases of Aging Pathway Via Stimulating Access to Research in Residency (MGH DAP StARR)
通过刺激住院医师研究参与 MGH 衰老途径疾病 (MGH DAP StARR)
- 批准号:
10592226 - 财政年份:2023
- 资助金额:
$ 119.21万 - 项目类别:
Multi-omic Brain Cell Atlas of Alzheimer's Disease Progression
阿尔茨海默病进展的多组学脑细胞图谱
- 批准号:
10461533 - 财政年份:2021
- 资助金额:
$ 119.21万 - 项目类别:
LRP1-tau interactions and Alzheimer Disease
LRP1-tau 相互作用与阿尔茨海默病
- 批准号:
10274154 - 财政年份:2021
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10332246 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
9914193 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10378606 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10620661 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center P30 Diversity Supplement Gaona
马萨诸塞州阿尔茨海默病研究中心 P30 多样性补充剂高纳
- 批准号:
10522320 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10511260 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
相似海外基金
Washington Obstetric-Fetal Pharmacology Research Unit
华盛顿产胎儿药理学研究单位
- 批准号:
7695403 - 财政年份:2004
- 资助金额:
$ 119.21万 - 项目类别: